BMS-394136
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


BMS-394136
Description :
BMS-394136 (compound 1) is a potent inhibitor of Kv 1.5, with an IC50 of 0.05 μM. BMS-394136 is a selective IKur inhibitor. BMS-394136 dose-dependently prolongs atrial effective refractory period (AERP) and action potential duration (APD) without effecting ventricular effective refractory period (VERP) . BMS-394136 can be used for acute atrial ischemia research[1].UNSPSC :
12352005Target :
Potassium ChannelType :
Reference compoundRelated Pathways :
Membrane Transporter/Ion ChannelApplications :
Neuroscience-NeuromodulationField of Research :
Cardiovascular DiseaseAssay Protocol :
https://www.medchemexpress.com/bms-394136.htmlSolubility :
10 mM in DMSOSmiles :
O=C(C1=C(NC2=CC=NN2[C@@H]1C3=CC(Cl)=C(C=C3)Cl)C)N4[C@@H](CCC4)C5=CC=C(C=C5)FMolecular Formula :
C24H21Cl2FN4OMolecular Weight :
471.35References & Citations :
[1]Gunaga P, et al. Selective IKur Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4- (pyridin-2-ylmethylamino) quinazolin-2-yl]pyridine-3-sulfonamide. J Med Chem. 2017 May 11;60 (9) :3795-3803.|[2]Dezhi Xing, et al. Abstract 12964: Acute Atrial Ischemia Increases the Activity of BMS-394136, a Selective IKur Inhibitor, on Atrial Refractoriness and APD. Originally published 23 Mar 2018. Circulation. 2010;122:A12964.Shipping Conditions :
Room temperatureScientific Category :
Reference compound1Clinical Information :
Phase 1CAS Number :
[343246-73-1]

